- Home
- CVRX vs AIRS Comparison
CVRX vs AIRS Comparison
Compare CVRX & AIRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVRX
- AIRS
- Stock Information
- Founded
- CVRX 2000
- AIRS 2012
- Country
- CVRX United States
- AIRS United States
- Employees
- CVRX N/A
- AIRS N/A
- Industry
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- AIRS Medical/Nursing Services
- Sector
- CVRX Health Care
- AIRS Health Care
- Exchange
- CVRX Nasdaq
- AIRS Nasdaq
- Market Cap
- CVRX 203.9M
- AIRS 166.3M
- IPO Year
- CVRX 2021
- AIRS 2021
- Fundamental
- Price
- CVRX $7.17
- AIRS $6.15
- Analyst Decision
- CVRX Buy
- AIRS Hold
- Analyst Count
- CVRX 7
- AIRS 3
- Target Price
- CVRX $14.00
- AIRS $3.75
- AVG Volume (30 Days)
- CVRX 165.0K
- AIRS 537.8K
- Earning Date
- CVRX 10-28-2025
- AIRS 11-07-2025
- Dividend Yield
- CVRX N/A
- AIRS N/A
- EPS Growth
- CVRX N/A
- AIRS N/A
- EPS
- CVRX N/A
- AIRS N/A
- Revenue
- CVRX $54,652,000.00
- AIRS $165,109,000.00
- Revenue This Year
- CVRX $11.32
- AIRS N/A
- Revenue Next Year
- CVRX $18.58
- AIRS $5.14
- P/E Ratio
- CVRX N/A
- AIRS N/A
- Revenue Growth
- CVRX 23.11
- AIRS N/A
- 52 Week Low
- CVRX $4.30
- AIRS $1.53
- 52 Week High
- CVRX $18.55
- AIRS $9.20
- Technical
- Relative Strength Index (RSI)
- CVRX 44.88
- AIRS 50.09
- Support Level
- CVRX $6.53
- AIRS $5.61
- Resistance Level
- CVRX $8.35
- AIRS $6.41
- Average True Range (ATR)
- CVRX 0.47
- AIRS 0.41
- MACD
- CVRX -0.11
- AIRS -0.03
- Stochastic Oscillator
- CVRX 35.16
- AIRS 49.59
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
About AIRS AirSculpt Technologies Inc.
AirSculpt Technologies Inc is a national provider of body contouring procedures delivering a premium consumer experience under its brand Elite Body Sculpture. Elite Body Sculpture, provides custom body contouring using the proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure. The company has one operating and reportable segment, direct medical procedure services.